Caplight Directory>Companies>Neurotez-preview>Neurotez


Neurotez

Neurotez

Private
Jersey City, New JerseyHealthcare & Life Scienceshttps://www.neurotez.com

Last Round

Crowdfunding

Sep 1, 2022

Est. Valuation

$45.29M

Total Funding Raised

$4.14M

Company Overview

Neurotez is a biopharmaceutical company focused on developing treatments for Alzheimer's patients with hyperleptinemia through advanced screening and characterization using biochemical, molecular, and cell biology in vivo models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales, Revenue Share

AI Layer

Non-AI

Keywords

Alzheimer's treatmenthormone replacement therapybiotechLeptin therapyclinical-stage biopharmaLeptin deficiencydisease-modifying therapyneurodegenerative diseaseamyloid beta inhibitortau protein inhibitorMild Cognitive ImpairmentMCIdrug discovery platformbiologic drugpeptide therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurotez Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurotez Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingSep 1, 2022
CrowdfundingNov 9, 2021
CrowdfundingJun 24, 2021
CrowdfundingFeb 26, 2018
GrantNov 3, 2010
View all Funding Rounds

Key People

Founding team and executive leadership

Nikolaos Tezapsidis

President CEO

Executive Team

Jukka Karjalainen

COO

Executive Team

Neurotez Investors

Notable investors and investment history

InvestorRounds
NIH RADxGrant
Internal Revenue ServiceGrant
NetcapitalCrowdfunding
View all Investors

Neurotez Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurotez Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurotez's valuation, stock price, and market status.

Firmographic Details

HeadquartersJersey City, New Jersey
Employee Range5
Year Founded2005
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.